通过功能性纳米药物调节细胞死亡途径,以获得强大的抗瘤免疫力
Yongjuan Li1,2,3, Yichen Guo1, Kaixin Zhang1
1School of Pharmaceutical Sciences, Henan Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, Henan, 450001, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 20, 2023
概括
纳米材料通过调节被编程的细胞死亡途径 (如铁和热) 来增强癌症免疫疗法. 这种方法提高了治疗效果,并减少了强大的抗瘤免疫反应的副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 癌症免疫疗法是主要的治疗方式.
- 已编程的细胞死亡途径 (铁,热,自,死,亡,亡) 与抗瘤免疫有关.
- 细胞死亡诱导剂的直接使用具有副作用和低效率等局限性.
研究的目的:
- 对调节细胞死亡以增强抗瘤免疫力的纳米医学策略进行审查.
- 总结免疫细胞的功能及其在癌症治疗中的作用.
主要方法:
- 对针对细胞死亡途径的纳米药物当前研究的综述.
- 分析免疫细胞类型及其在抗瘤反应中的功能.
主要成果:
- 纳米材料为诱导细胞死亡的药物递送提供了改进 (长循环,瘤积累,受控释放).
- 基于纳米医学的策略有效调节各种细胞死亡模式 (铁灭,热灭,自灭,死灭,灭,灭).
- 通过纳米药物调节细胞死亡,增强宿主抗瘤免疫反应.
结论:
- 纳米药物通过利用细胞死亡途径,对癌症免疫疗法充满希望.
- 未来的研究应该专注于优化纳米药物设计和了解免疫相互作用,以改善癌症治疗.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
924
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
924
The Extrinsic Apoptotic Pathway
6.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Tumor Immunotherapy
530
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
530
Cells of the Innate Immune Response
1.7K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


